Shenzhen-listed traditional medicine makers ride high on endorsement by public face of China’s fight against coronavirus



a man cutting a cake: A traditional Chinese medicine pharmacy in Weinan City, in China’s northwest Shaanxi Province. The overall industry has stalled, with only 17 out of 68 TCM makers recording year-on-year growth in revenue in the first half of 2020. Photo: Xinhua


A traditional Chinese medicine pharmacy in Weinan City, in China’s northwest Shaanxi Province. The overall industry has stalled, with only 17 out of 68 TCM makers recording year-on-year growth in revenue in the first half of 2020. Photo: Xinhua

Two Shenzhen-listed makers of traditional Chinese medicine (TCM), Shijiazhuang Yiling Pharmaceutical and Tianjin Chase Sun Pharmaceutical, have reaped stunning gains this year, riding on endorsements by the public face of China’s successful fight against the coronavirus pandemic.

Yiling reported a 57 per cent jump in net profit to 714 million yuan (US$106 million) for the first half of 2020, while its stock price surged by as much as 245 per cent between January and mid April, hitting its highest level since it went public in 2011. Chase Sun recorded 2.8 billion yuan in revenue for the first half, a 22 per cent increase compared with the same period last year.

Their

Read More

U.S. Government Asks Vaccine Makers To Hold Filing for Authorization Until They Have Enough Doses to Distribute

President Trump Makes Statement On Vaccine Development
President Trump Makes Statement On Vaccine Development

Moncef Slaoui, head of the White House’s “Operation Warp Speed” project to develop a coronavirus vaccine, listens to U.S. President Donald Trump deliversremarks about vaccine development in the Rose Garden of the White House on May 15, 2020 in Washington, DC. Credit – Drew Angerer—Getty Images

As the COVID-19 pandemic enters its 10th month, the pressure to develop an effective vaccine, or vaccines, continues to mount. Speaking at the Johns Hopkins University and University of Washington Vaccine Symposium online, Dr. Moncef Slaoui, scientific head of Operation Warp Speed—the government organization funding and supporting development and distribution of COVID-19 vaccines—provided the latest updates on when a vaccine (and how many doses) might be available in coming months.

Perhaps most strikingly, Slaoui said that the government has told vaccine manufacturers not to seek authorization of their drugs from the Food and Drug Administration (FDA) until

Read More

Gov’t Bows to Vax Makers’ Demands? 2nd Wave Hits Europe; FDA Wants Makena Pulled

Note that some links may require registration or subscription.

The White House is blocking new FDA guidelines that would stiffen requirements for authorizing COVID-19 vaccines, after manufacturers reportedly objected to the guidance. (New York Times, Politico)

White House Press Secretary Kayleigh McEnany and Pastor Greg Laurie of the Harvest Christian Fellowship megachurch were the latest attendees at a recent White House event to report a positive coronavirus test. MedPage Today has a running list here.

Perhaps the most at risk White House staffers, however, are the 100 members of the White House’s residence staff. (The Atlantic)

Finally: the CDC acknowledges the potential for airborne SARS-CoV-2 transmission.

As of 8:00 a.m. ET Tuesday, the estimated U.S. COVID-19 toll reached 7,459,102 cases and 210,196 deaths — up 40,364 and 462, respectively, since the same time Monday.

The Northeast and Midwest are experiencing surges, and new cases have risen

Read More